According to a recent LinkedIn post from Phantom Neuro, the company’s technology was featured on the science and technology show Core Memory hosted by Ashlee Vance. The segment reportedly focused on Phantom Neuro’s minimally invasive, muscle-based implant system that enables real-time control of prosthetic limbs and robotic systems without brain surgery.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post notes that Founder & CEO Connor Glass discussed how muscle-machine interfaces can help people with physical disabilities regain function, alongside upper limb amputee Alex Smith. The episode also touched on broader assistive technology use cases, potential defense applications, and the future of more intuitive human-machine interaction.
For investors, this media exposure suggests growing visibility for Phantom Neuro within the neurotechnology and robotics ecosystem. Increased awareness could support future fundraising, strategic partnerships, and early commercial traction if the technology can demonstrate clinical efficacy and scalable deployment.
The mention of defense-related applications may point to potential demand from government or military customers, albeit with long and complex procurement cycles. The focus on assistive technology indicates a core healthcare and rehabilitation market, where reimbursement pathways, regulatory approvals, and integration with existing prosthetics manufacturers will be critical to long-term revenue generation.
Positioning around non-brain-implant solutions could differentiate Phantom Neuro from firms pursuing more invasive neural interfaces. If the company can maintain performance while lowering surgical risk and cost, it may gain a competitive advantage in adoption among both patients and clinicians, although the post does not provide data on clinical outcomes or commercialization timelines.

